Какова цена за Beta Bionics, Inc. (BBNX)

Цена за Beta Bionics, Inc. (BBNX) Это $19.81

Какова рыночная капитализация для Beta Bionics, Inc. (BBNX)

Рыночная капитализация для Beta Bionics, Inc. (BBNX) Это $891.32M

Beta Bionics, Inc. (BBNX) Дивидендная доходность

Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.

Год	Дивидендная доходность	Изменить
Недостаточно данных для указанных дат.

Год

Дивидендная доходность

Изменить

Недостаточно данных для указанных дат.

Компания	Дивидендная доходность	Страна
Abbott Laboratories ABT.US	2.23%	US
Stryker Corporation SYK.US	1.03%	US
Medtronic plc MDT.US	3.69%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Siemens Healthineers AG SHL.DE	0.00%	DE

Компания

Дивидендная доходность

Страна